EVGN Evogene Ltd.

Evogene Ltd is a biotechnology company for the improvement of crop productivity. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  02/19/2013
Outstanding shares:  40,621,124
Average volume:  359,041
Market cap:   $82,460,882
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    M4119S104
Valuation   (See tab for details)
PE ratio:   -2.92
PB ratio:   1.39
PS ratio:   85.01
Return on equity:   -47.03%
Net income %:   -2,942.68%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy